Recursion Pharmaceuticals (RXRX) P/E (2021 - 2026)
Recursion Pharmaceuticals (RXRX) P/E from Apr 16, 2021 to Jul 21, 2026. The TTM Recursion Pharmaceuticals (RXRX) P/E is -2.67. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Recursion Pharmaceuticals (RXRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.67 | -6.62% |
| 2025 | -2.86 | -50.83% |
| 2024 | -5.82 | -43.28% |
| 2023 | -10.26 | +27.28% |
| 2022 | -8.06 | -44.42% |
| 2021 | -14.50 | N/A |
Comparison Recursion Pharmaceuticals (RXRX) P/E with competitors
Recursion Pharmaceuticals (RXRX) P/E is -2.67.